Cerity Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $768K | Buy |
45,837
+1,291
| +3% | +$21.6K | ﹤0.01% | 1646 |
|
|
2025
Q1 | $685K | Sell |
44,546
-3,166
| -7% | -$48.7K | ﹤0.01% | 1595 |
|
|
2024
Q4 | $981K | Buy |
47,712
+6,311
| +15% | +$130K | ﹤0.01% | 1417 |
|
|
2024
Q3 | $746K | Sell |
41,401
-2,361
| -5% | -$42.5K | ﹤0.01% | 1551 |
|
|
2024
Q2 | $711K | Buy |
43,762
+1,649
| +4% | +$26.8K | ﹤0.01% | 1376 |
|
|
2024
Q1 | $594K | Buy |
42,113
+24,085
| +134% | +$340K | ﹤0.01% | 1521 |
|
|
2023
Q4 | $188K | Buy |
+18,028
| New | +$188K | ﹤0.01% | 1725 |
|
|
2019
Q1 | – | Sell |
-18,506
| Closed | -$285K | – | 573 |
|
|
2018
Q4 | $285K | Buy |
18,506
+3,931
| +27% | +$60.5K | 0.02% | 413 |
|
|
2018
Q3 | $314K | Sell |
14,575
-82
| -0.6% | -$1.77K | 0.02% | 411 |
|
|
2018
Q2 | $356K | Buy |
14,657
+2,971
| +25% | +$72.2K | 0.03% | 389 |
|
|
2018
Q1 | $200K | Sell |
11,686
-1,297
| -10% | -$22.2K | 0.02% | 503 |
|
|
2017
Q4 | $246K | Buy |
+12,983
| New | +$246K | 0.02% | 487 |
|